OmniaBio

OmniaBio is redefining the future of cell therapy manufacturing through its proprietary AI-powered Intelligent Factory™. Purpose-built to accelerate discoveries and industrialize production, the Intelligent Factory™ integrates artificial intelligence and automation across the entire manufacturing lifecycle. With a focus on autologous CAR-T and other advanced therapies, OmniaBio’s platform enables scalable, efficient, and high-fidelity production by embedding predictive analytics, robotic bioprocessing, and digital quality systems into a unified, closed-loop system. This approach not only enhances throughput and consistency but also positions OmniaBio as a next-generation CDMO partner for innovators seeking to bring life-saving therapies to patients faster.

International Point of Care Inc. | Fortis Life Sciences

International Point of Care Incorporated (IPOC) products & services are fully integrated into Fortis Life Sciences. International Point of Care Incorporated (IPOC), based in Toronto, Canada, is a leading provider of innovative solutions for the in-vitro diagnostic industry and research and development community. With a strong focus on rapid point-of-care testing, we offer contract IVD manufacturing, lateral flow components (including Primecare blood separation membrane), and custom lyophilization services (including lyophilized beaded reagents, LBR) to meet the diverse needs of our global healthcare clientele. Our 36,000 sq ft manufacturing facility is an FDA-registered medical device establishment (cGMP-compliant) and ISO 13485:2016 certified. Our products and services include: • Fine biochemicals (recombinant proteins, monoclonal, and polyclonal antibodies) • Proprietary asymmetric blood separation membranes for application in point-of-care diagnostic tests • Contract lyophilization services to address commercial-scale demand • Contract manufacturing for lateral flow tests including formulation, production assembly, and packaging

BioXcel, LLC

BioXcel LLC utilizes advanced technologies such as AI (Artificial Intelligence) to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel is optimizing research and development for productivity and creating novel and transformative medicines (or drugs). BioXcel's AI-enabled platform, EvolverAI helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process.

MYSTICAL BIOTECH - India

Mystical Biotech Pvt Ltd. is an Indian Pharmaceutical / Nutraceutical company based in Bengaluru, Karnataka incorporated in 2005. We manufacture innovative and research-based probiotics and Nutraceuticals and have sales both domestically and globally. We have established world-class manufacturing facilities by leveraging state-of-the-art technology, incorporating best practices and adhering to stringent regulatory compliances. Our plant is approved by prestigious US FDA, WHO-GMP, HALAL, KOSHER, FSSAI, ISO –HACCP and other foreign health authorities. Our R&D capabilities include, formulation development, analytical development, process optimization and conducting stability studies. We possess end-to-end capabilities – from Lab scale development to Pilot scale up and from commercializing the product for manufacturing to marketing globally. We are known for our Quality, Reliability, Capabilities, Expertise, and Development. The company has achieved global recognition within a very short span of time and has major global expansion plans for the near future.

Lyrata Inc

UofT Hatchery NEST2020/Go-To-Market startup